Excel Industries Limited (EXCELINDUS.NS)
INR 1355.95
(3.31%)
INR 1355.95
(3.31%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 880.15 Million | 1.25 Billion | 1.08 Billion | 908.56 Million | 1.1 Billion | 1.35 Billion |
| Net Income | 170.1 Million | 1.05 Billion | 2.13 Billion | 1 Billion | 1.14 Billion | 2.34 Billion |
| Depreciation & Amortization | 314.25 Million | 313.61 Million | 306.55 Million | 271.53 Million | 227.8 Million | 181.24 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 558.3 Million | 245.41 Million | -747.71 Million | -110.56 Million | 70.5 Million | -392.6 Million |
| Other non-cash items | -286.28 Million | -363.23 Million | -604.03 Million | -260.5 Million | -345.58 Million | -779.16 Million |
| Investing Cash Flow | -647.17 Million | -1.17 Billion | -1.04 Billion | -525.97 Million | -613.84 Million | -1.11 Billion |
| Investments in PPE | -323.64 Million | -326.55 Million | -738.94 Million | -477.15 Million | -657.5 Million | -465.01 Million |
| Acquisitions | 11.08 Million | -4.93 Million | -100.01 Million | -75 Million | -675 Million | 684.55 Million |
| Investment purchases | -3.87 Billion | -2.1 Billion | -396.78 Million | -57.21 Million | -722.93 Million | -926.65 Million |
| Sales/Maturities of investments | 3.53 Billion | 1.18 Billion | 55.45 Million | 5 Million | 1.32 Billion | 242.1 Million |
| Other Investing Activities | 1000.00 | 74.06 Million | 139.42 Million | 78.38 Million | 118.09 Million | -647.13 Million |
| Financing Cash Flow | -157.05 Million | -345.8 Million | -168.89 Million | -168.33 Million | -314.59 Million | -243.86 Million |
| Debt repayment | -15.06 Million | -43.44 Million | -8.57 Million | -152.31 Million | -8.32 Million | -29.64 Million |
| Dividends payments | -141.89 Million | -282.15 Million | -141.57 Million | - | -435.69 Million | -189.43 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -73 Thousand | -20.2 Million | -18.75 Million | -16.02 Million | 129.42 Million | -24.78 Million |
| Accounts receivables | -279.41 Million | 439.22 Million | -266.97 Million | -245.57 Million | 108.95 Million | -351.79 Million |
| Accounts payables | 781.17 Million | -736.57 Million | 569.25 Million | 180.28 Million | 36.99 Million | 130.89 Million |
| Inventory | 250.53 Million | 337.83 Million | -962.54 Million | 87.48 Million | -89.72 Million | -129.02 Million |
| Other working capital | -193.99 Million | 204.93 Million | -87.44 Million | -132.76 Million | 14.28 Million | -42.68 Million |
| Cash at beginning of period | 46.5 Million | 303.07 Million | 423.48 Million | 209.23 Million | 35.89 Million | 40.34 Million |
| Cash at end of period | 124.32 Million | 35.72 Million | 303.07 Million | 423.48 Million | 209.23 Million | 35.89 Million |
| Capital Expenditure | -323.64 Million | -326.55 Million | -738.94 Million | -477.15 Million | -657.5 Million | -465.01 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 77.81 Million | -267.35 Million | -120.4 Million | 214.24 Million | 173.34 Million | -4.45 Million |
| Free Cash Flow | 556.5 Million | 926.92 Million | 350.39 Million | 431.41 Million | 444.27 Million | 886.53 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 310.21 Million | 170.1 Million | 66.73 Million | 26.75 Million | 17.85 Million | 58.75 Million |
| Depreciation & Amortization | - | 314.25 Million | - | 78.51 Million | 155.98 Million | 88.44 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 558.3 Million | - | - | 548.32 Million | - |
| Other non-cash items | -310.21 Million | -286.28 Million | -66.73 Million | -26.75 Million | -17.85 Million | -58.75 Million |
| Investing Cash Flow | - | -647.17 Million | - | - | -572.21 Million | - |
| Investments in PPE | - | -323.64 Million | - | - | -138.8 Million | - |
| Acquisitions | - | 11.08 Million | - | - | - | - |
| Investment purchases | - | -3.87 Billion | - | - | - | - |
| Sales/Maturities of investments | - | 3.53 Billion | - | - | - | - |
| Other Investing Activities | - | 1000.00 | - | - | -433.41 Million | - |
| Financing Cash Flow | - | -157.05 Million | - | - | -158.26 Million | - |
| Debt repayment | - | -15.06 Million | - | - | - | - |
| Dividends payments | - | -141.89 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -73 Thousand | - | - | -17.14 Million | - |
| Accounts receivables | - | -279.41 Million | - | - | -98.34 Million | - |
| Accounts payables | - | 781.17 Million | - | - | - | - |
| Inventory | - | 250.53 Million | - | - | 646.66 Million | - |
| Other working capital | - | -193.99 Million | - | - | - | - |
| Cash at beginning of period | - | 46.5 Million | - | 50.34 Million | 13.19 Million | 46.5 Million |
| Cash at end of period | - | 124.32 Million | - | 207.37 Million | 37.15 Million | 223.4 Million |
| Capital Expenditure | - | -323.64 Million | - | - | -138.8 Million | - |
| Effect of forex changes on cash | - | - | - | - | 35.72 Million | - |
| Net cash flow / Change in cash | - | 77.81 Million | - | 157.02 Million | 23.95 Million | 176.89 Million |
| Free Cash Flow | - | 556.5 Million | - | 157.02 Million | 593.1 Million | 176.89 Million |
AARTIPHARM
ALB
ATH
4265
TPSRF
MAGADSUGAR